Post-earnings recap
Reported
Thu, Apr 16, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Abbott Laboratories reported an EPS of $0.65, slightly missing expectations. Despite this, the stock rose by 5.56%, indicating that investors may have reacted positively to other aspects of the company's performance or outlook not detailed in the earnings report.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.65 | N/A | -1.70% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.
Est. EPS
—
Est. Rev
—
Impl. Move
—